PBI49 A Comparative Analysis of Cost-Effectiveness Evaluations of Cell and GENE Therapies across HTA Organisations
Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.127
https://www.valueinhealthjournal.com/article/S1098-3015(20)32383-4/fulltext
Section Title :
Section Order :
10093
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32383-4&doi=10.1016/j.jval.2020.08.127